Jasper Mullenders

Hycult Biotech (Netherlands) — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index4.3kcitations46works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(9), Bladder and Urothelial Cancer Treatments(5), CRISPR and Genetic Engineering(5), TGF-β signaling in diseases(5), Cytokine Signaling Pathways and Interactions(5)

Publications46 total

Abstract 4690: SC-2882, a novel QPCTL inhibitor, with anti-tumor activity in solid tumor models
Cancer Research·2024
Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation
British Journal of Cancer·2023· 21 citedOpen Access
Supplementary Data from Interleukin-1R–Associated Kinase 2 Is a Novel Modulator of the Transforming Growth Factor β Signaling Cascade
2023Open Access
Supplementary Data from Interleukin-1R–Associated Kinase 2 Is a Novel Modulator of the Transforming Growth Factor β Signaling Cascade
2023Open Access
Data from Interleukin-1R–Associated Kinase 2 Is a Novel Modulator of the Transforming Growth Factor β Signaling Cascade
2023Open Access
Data from Interleukin-1R–Associated Kinase 2 Is a Novel Modulator of the Transforming Growth Factor β Signaling Cascade
2023Open Access
Supplementary Data from Candidate Biomarkers of Response to an Experimental Cancer Drug Identified through a Large-scale RNA Interference Genetic Screen
2023Open Access
Data from Candidate Biomarkers of Response to an Experimental Cancer Drug Identified through a Large-scale RNA Interference Genetic Screen
2023Open Access
Supplementary Data from Candidate Biomarkers of Response to an Experimental Cancer Drug Identified through a Large-scale RNA Interference Genetic Screen
2023Open Access
Data from Candidate Biomarkers of Response to an Experimental Cancer Drug Identified through a Large-scale RNA Interference Genetic Screen
2023Open Access
Urine-derived bladder cancer organoids (urinoids) as tool for cancer longitudinal response monitoring and therapy adaptation
2023· 3 citedOpen Access
Abstract 126: HUB Organoids: bringing the 'patient in the lab' for preclinical and clinical development
Cancer Research·2021· 1 cited
Abstract 2977: Organoid-T-cell co-cultures for preclinical testing of adoptive cell and cancer immunotherapy
Cancer Research·2021· 1 cited
Early invasion of the bladder wall by solitary bacteria protects UPEC from antibiotics and neutrophil swarms in an organoid model
Cell Reports·2021· 50 citedOpen Access
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
npj Precision Oncology·2021· 262 citedOpen Access
Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids
Journal of Cystic Fibrosis·2021· 68 citedOpen Access
Early invasion of uropathogenic <i>Escherichia coli</i> into the bladder wall by solitary bacteria that are protected from antibiotics and neutrophil swarms in an organoid model
2020Open Access
Abstract LB-008: Patient derived organoids: Bringing the "patient in the lab" for pre-clinical and clinical development
Cancer Research·2020
Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids
STAR Protocols·2020· 122 citedOpen Access
CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank
Cell stem cell·2020· 212 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

René Bernards(18), Roderick L. Beijersbergen(17), Iannis Aifantis(11), Miranda M.W. van Dongen(10), Thomas Trimarchi(8), Sylvia F. Boj(8), Armida W. M. Fabius(8), Beatriz Aranda-Orgillés(7), Hans Clevers(7), Bryan H. King(6), Aristotelis Tsirigos(6), Katrien Berns(5), Sofia Bakogianni(5), Rudolf Jaenisch(5), Wolfgang von der Saal(5), Ulrike Reiff(5), Rogier van Willigen(5), Georg Tiefenthaler(5), Christian Klein(5), Hendrik J. Kuiken(5)